Alterations in serotonin and neuropeptide Y content of cerebrovascular sympathetic nerves following experimental subarachnoid hemorrhage.
The effect of an experimental subarachnoid hemorrhage (SAH) upon neurotransmitter content in sympathetic nerves supplying the major cerebral arteries of the rat has been examined by immunohistochemical analysis and high performance liquid chromatography with electrochemical detection (HPLC-ECD). In particular, changes that occur in sympathetic nerve content of the vasoconstrictor agents serotonin (5-HT) and neuropeptide Y (NPY), which are colocalized with noradrenaline, were assessed. Subarachnoid hemorrhage was induced by a single injection of autologous arterial blood into the cerebrospinal fluid (CSF) space of the cisterna magna. The density of 5-HT-containing and NPY-containing perivascular nerve fibers per unit area of vessels was measured at defined intervals from 15 min to 5 days post-SAH. In addition, an HPLC study was performed to quantify the actual amounts of 5-HT and noradrenaline present in circle of Willis vessels at 3 h post-SAH. Comparison was made with sham-operated animals and animals that received a cisternal injection of buffered saline in place of blood. Our results reveal a major increase in cerebrovascular sympathetic nerve content of serotonin, arising by uptake, presumably from subarachnoid blood clot, within the first 3 h post-SAH. Neuropeptide Y content, however, decreased from 3 up to 48 h posthemorrhage. By 3 days post-SAH, when the majority of subarachnoid clot had resorbed, the sympathetic nerve content of both NPY and 5-HT was restored to normal. This pattern of change was not observed in either sham-operated or saline-injected controls.
Jackowski
A
A
Department of Anatomy and Developmental Biology, University College London, U.K.
Crockard
A
A
Burnstock
G
G
Lincoln
J
J
D000818:Animals; D002536:Cerebral Arteries / Q000294:innervation*; D002851:Chromatography, High Pressure Liquid; D002997:Clomipramine / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D007150:Immunohistochemistry; D007700:Kinetics; D008297:Male; D009412:Nerve Fibers / Q000187:drug effects / Q000378:metabolism; D009478:Neuropeptide Y / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism*; D013345:Subarachnoid Hemorrhage / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000378:metabolism*
D006892:Hydroxydopamines; D009478:Neuropeptide Y; D012701:Serotonin; D016627:Oxidopamine; D002997:Clomipramine; D009638:Norepinephrine